DrugDev Hosts New Educational Webinar, “Why Doctors are Crucial to Increased Representation of Minorities in Clinical Research” April 16, with Dr. Fabian Sandoval
KING OF PRUSSIA, PA and LONDON, UK (PRWEB) April 10, 2015 -- DrugDev will host an educational webinar, “Why Doctors are Crucial to Increased Representation of Minorities in Clinical Research” April 16, with Fabian Sandoval MD, CEO and Medical Director of the Emerson Clinical Research Institute and DrugDev Director of Investigator Engagement Claire Sears, PhD. The complimentary webinar featuring an interactive and evidence-based discussion will provide actionable steps to improve representative of minorities in clinical trials.
Webinar: Why Doctors are Crucial to Increased Representation of Minorities in Clinical Research
Speakers: Fabian Sandoval MD, CEO and Medical Director of the Emerson Clinical Research Institute; Claire Sears, PhD, DrugDev Director of Investigator Engagement
Date: April 16, 2015
Time: 10:00-11:00am EDT
Click to register
This webinar is complimentary
In this age of personalized medicine, it seems obvious that a clinical trial studying a new medicine should include representatives from the entire population to whom it may be prescribed. However, this is not the case for many of the studies currently being conducted. While globalization has broadened the overall diversity of participation in clinical trials, in the US the patients taking part in clinical trials are not characteristic of the population at large.
Dr. Sandoval will lead an open and frank discussion on how doctors can ensure diverse patient representation in clinical trials. He will discuss the important work being done in his clinic to support participation of more patients from ethnic minorities in clinical trials. And, he will offer guidance on how the industry as a whole can work better to provide clinical trial opportunities to a broad patient community.
About the Speakers
Dr. Fabian Sandoval has over 18 years of bench to bedside research experience. He received his Bachelors of Science in molecular and cellular biology from Marymount University, and his Doctorate of Medicine (Medical Surgeon Degree) from the Autonomous University of Guadalajara, School of Medicine. Hear more about Dr. Sandoval’s work in this DrugDev podcast http://resources.drugdev.com/drsandoval-podcast
Claire Sears emphasizes keeping an open line of communication with doctors. She firmly believes closer relationships between investigators, sites and industry can bring great benefits to the clinical trials process. She has a PhD in cardiovascular physiology.
About DrugDev
DrugDev is an innovative technology company which provides cloud-based solutions to help sponsors, CROs and investigators do more clinical trials together. Built around the largest global network of active opted-in investigators, DrugDev’s unified solutions suite optimizes site selection and startup, investigator payments and clinical operations. DrugDev also serves as the trusted third-party host of the revolutionary Investigator Databank collaboration and powers the TransCelerate Investigator Registry. Learn why 9 of the top 10 sponsors and 4 of the top 5 CROs rely on DrugDev technology to do more trials at drugdev.com.
Brenda Nashawaty, DrugDev, http://www.drugdev.com, +1 617-688-3253, [email protected]
Share this article